Clinical Trial

A Study of TLC590 for Postsurgical Pain Following Bunionectomy

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a Phase 3, randomized, double-blind, comparator- and placebo-controlled study to evaluate analgesic efficacy and safety of TLC590 via local infiltration in adult subjects following bunionectomy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-28; most recent amendment 2026-06-30.
Status change: Recruiting → Active, Not Recruiting 2026-06-30
Status change: Not Yet Recruiting → Recruiting 2025-11-24
Trial Details
NCT Number NCT07222748
Lead Sponsor TLC Biopharmaceuticals, Inc.
Conditions Postoperative Pain
Enrollment 304 participants
Start Date 2025-11-17
Primary Completion 2026-06-12 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-02